DALUTRAFUSP ALFA
UNII KNL22F1WCK

Substance Identification & Data

This profile provides standardized clinical and technical data for Dalutrafusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KNL22F1WCK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2419918-89-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
KNL22F1WCK
CAS Registry Number
2419918-89-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DALUTRAFUSP ALFA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11814
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dalutrafusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

DALUTRAFUSP ALFA
DALUTRAFUSP ALFA [INN]
IMMUNOGLOBULIN G1 (297-ALANINE), ANTI-(HUMAN CD73 ANTIGEN) (HUMAN MONOCLONAL HUG04-TRAP .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)4 FUSION PROTEIN WITH 1-136-TRANSFORMING GROWTH FACTOR .BETA. RECEPTOR TYPE II (HUMAN), DISULFIDE WITH HUMAN MONOCLONAL HUG04-TRAP .KAPPA.-CHAIN, DIMER